Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Nephrotic Syndrome

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Nephrotic Syndrome in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19902 (18.18)18.7374
1990's8 (72.73)18.2507
2000's1 (9.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diamond, JR; Kees-Folts, D1
Ardiles, L; Biancone, L; Camussi, G; Kunick, M; Mezzano, S; Montrucchio, G; Olavarria, F; Silvestro, L1
Frenkel, RA; Johnston, JM; Mimura, K; Muguruma, K; Zhao, B1
Ren, G; Ye, R1
Coker, I; Cura, A; Hüseyinov, A; Kabasakal, C; Kantar, M; Mir, S1
Daikhin, Y; Moskaleva, ES; Pinelis, VG; Serebruany, VL; Svetlov, SI1
Camici, M; Sagripanti, A1
Egido, J; Gomez-Chiarri, M; Gonzalez, E; Lerma, JL; Ortiz, A1
Braquet, P; Egido, J; Gómez-Chiarri, M; González, E; Hernando, L; Lerma, JL; Mampaso, F; Ortíz, A; Robles, A1
Braquet, P; Bricio, T; Cobo, ME; Egido, J; González, E; Hernando, L; Mampaso, FM; Martínez-Montero, JC; Pirotzky, E1
Kato, K; Nozawa, R; Sakurai, K; Suzuki, H; Suzuki, J; Suzuki, S1

Reviews

2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Nephrotic Syndrome

ArticleYear
Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome.
    American journal of nephrology, 1993, Volume: 13, Issue:5

    Topics: Animals; Eicosanoids; Glomerulosclerosis, Focal Segmental; Humans; Hyperlipidemias; Macrophages; Nephrotic Syndrome; Platelet Activating Factor; Transforming Growth Factor beta

1993
The role of platelet-activating factor (PAF) in experimental glomerular injury.
    Lipids, 1991, Volume: 26, Issue:12

    Topics: Animals; Glomerulonephritis; Inflammation; Kidney; Kidney Glomerulus; Nephrotic Syndrome; Platelet Activating Factor

1991

Other Studies

9 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Nephrotic Syndrome

ArticleYear
Detection of platelet-activating factor in plasma of patients with streptococcal nephritis.
    Journal of the American Society of Nephrology : JASN, 1993, Volume: 4, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Blood Platelets; Child; Child, Preschool; Female; Glomerulonephritis; Humans; Male; Middle Aged; Nephrotic Syndrome; Platelet Activating Factor; Platelet Activation; Scabies; Serotonin; Skin Diseases, Infectious; Streptococcal Infections

1993
Changes in glycerophospholipid profile in experimental nephrotic syndrome.
    Metabolism: clinical and experimental, 1996, Volume: 45, Issue:7

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Kidney; Liver; Male; Microsomes; Mitochondria; Nephrotic Syndrome; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipases A; Phospholipids; Plasmalogens; Platelet Activating Factor; Proteins; Rats; Rats, Wistar

1996
[Changes in urinary excretion of platelet activating factor and its significance in patients with primary nephrotic syndrome].
    Zhonghua nei ke za zhi, 1996, Volume: 35, Issue:2

    Topics: Adult; Female; Humans; Male; Middle Aged; Nephrotic Syndrome; Platelet Activating Factor; Proteinuria

1996
Plasma and urinary platelet activating factor concentrations and leukotriene releasing activity of leukocytes in steroid sensitive nephrotic syndrome of childhood.
    Acta paediatrica Japonica : Overseas edition, 1998, Volume: 40, Issue:1

    Topics: Adolescent; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Humans; Leukocytes; Leukotrienes; Male; Nephrotic Syndrome; Platelet Activating Factor

1998
Decreased intraplatelet Ca2+ release and ATP secretion in pediatric nephrotic syndrome.
    Pediatric nephrology (Berlin, Germany), 1999, Volume: 13, Issue:3

    Topics: Adenosine Triphosphate; Adolescent; Blood Platelets; Calcium; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Intracellular Fluid; Male; Nephrotic Syndrome; Platelet Activating Factor; Thrombin

1999
Plasma platelet activating factor in nephrotic syndrome.
    Minerva medica, 2001, Volume: 92, Issue:5

    Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Nephrotic Syndrome; Platelet Activating Factor; Proteinuria; Radioimmunoassay

2001
Evidence suggesting a role for platelet-activating factor (PAF) in experimental nephrotic syndrome.
    International journal of tissue reactions, 1990, Volume: 12, Issue:4

    Topics: Acetates; Animals; Doxorubicin; Kidney; Kidney Glomerulus; Male; Nephrotic Syndrome; Platelet Activating Factor; Platelet Membrane Glycoproteins; Proteinuria; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Time Factors

1990
Interstitial mononuclear cell infiltrates in experimental nephrosis: effect of PAF antagonist.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1989, Volume: 4, Issue:12

    Topics: Acetates; Animals; Antibodies, Monoclonal; Disease Models, Animal; Diterpenes; Doxorubicin; Ginkgolides; Immunoenzyme Techniques; In Vitro Techniques; Kidney; Kidney Glomerulus; Lactones; Male; Nephritis, Interstitial; Nephrotic Syndrome; Platelet Activating Factor; Proteinuria; Puromycin; Rats; Rats, Inbred Strains

1989
[Effect of a specific antagonist of platelet-activating factor, FR-900452, on proteinuria and urinary thromboxane excretion in aminonucleoside nephrotic rats].
    Nihon Jinzo Gakkai shi, 1988, Volume: 30, Issue:8

    Topics: Animals; Indoles; Male; Nephrotic Syndrome; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thromboxane A2

1988